# psoriasis - deepseek-v4-flash

- Benchmark system: E2seq + Agent RAG
- Repeat: 1
- Task type: DISEASE-STATE
- Tissue / sample source: lesional skin
- Comparison or endpoint: psoriatic lesional skin versus normal control skin
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: DeepSeek / deepseek-v4-flash
- Message SHA-256: d1a33d3f606c81814c4fb94a6c63c8f1abebd3bde37d769e82eae4772d8ff873
- Response HTTP status: 200
- Prompt tokens: 15929
- Completion tokens: 6269
- Reasoning tokens: 0
- Total tokens: 22198
- API requests reported: 1
- Elapsed seconds: 271.77
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1150.303
- Question handoff seconds: 1163.566
- Final benchmark system: E2seq; file rank 1/5; original repeat 1; model vendor: DeepSeek

---
# Multidimensional Interpretation of Psoriatic Lesional Skin Transcriptomic Data

## 1. Overall Biological Interpretation

The dataset comprises 100 differentially expressed genes (90 upregulated, 10 downregulated) in psoriatic lesional skin versus normal skin, all with FDR ≤ 0.01 (P values from ~1.3e-150 to ~4.4e-63). The most striking feature is the **massive upregulation of epidermal differentiation, antimicrobial, and IL-17/IL-36-driven inflammatory programs**, with several genes showing log2FC > 7 (IL36A: 11.37, DEFB4A: 11.18, DEFB4B: 11.03, S100A7A: 9.83, PI3: 9.24, SERPINB4: 9.12, S100A12: 8.33).

The dominant biological picture is that of **aberrant keratinocyte differentiation coupled with innate immune activation and neutrophil/myeloid recruitment**. The cornified envelope components (SPRR2A-G, LCE3A/D, KRT6A, PI3), S100 alarmins, and β-defensins are all strongly upregulated, consistent with the well-established psoriatic "regenerative maturation" phenotype where keratinocytes express markers of both hyperproliferation and premature differentiation. Simultaneously, the IL-36 axis (IL36A, IL36G, IL36RN), IL-20 family cytokines (IL19, IL20, IL26), and chemokine/neutrophil markers (CXCL13, CXCR2, S100A8/A9/A12) indicate a coordinated type-17/type-20 inflammatory milieu.

The small downregulated set (10 genes) includes BTC (betacellulin, log2FC -4.30), CYP2W1, UGT3A2, SAPCD1, and several long non-coding RNAs (LOC107984452, LINC02660, WAKMAR1), suggesting suppression of certain metabolic/xenobiotic and growth-factor signaling programs in lesional skin.

---

## 2. Core Biological Programs

### Program 1: IL-36/IL-17-Driven Innate Inflammation
- **Direction**: Upregulated
- **Supporting genes**: IL36A (log2FC 11.37), IL36G (5.68), IL36RN (3.01), IL19 (7.58), IL20 (5.67), IL26 (4.36), IRAK2 (2.08), ZC3H12A (3.85), TNIP3 (7.28), CXCL13 (5.89), CXCR2 (2.70)
- **Standardized pathway**: KEGG IL-17 signaling pathway; Reactome Interleukin-36 pathway (R-HSA-9014826); Reactome Interleukin-20 family signaling (R-HSA-8854691)
- **Explanation**: IL36A and IL36G are the most strongly induced genes in the entire dataset (log2FC > 11 and > 5.7 respectively). These cytokines signal through IL1RL2/IL1RAP, activating NF-κB and MAPK pathways in keratinocytes. The co-upregulation of IL36RN (the natural IL-36 receptor antagonist) represents a compensatory feedback loop. IRAK2 and ZC3H12A (also known as Regnase-1, a negative regulator of inflammatory mRNA) further indicate active TLR/IL-1R signaling. The IL-20 family cytokines (IL19, IL20, IL26) are established psoriatic mediators that promote keratinocyte hyperproliferation.
- **Evidence strength**: Strong. Multiple independent genes across the IL-36 and IL-17 signaling axes are concordantly upregulated with extreme statistical significance. The IL-17 pathway is a validated therapeutic target in psoriasis (biologicals targeting IL-17A/IL-17RA).
- **Limitations**: This is a bulk tissue analysis; the relative contribution of keratinocytes versus infiltrating immune cells cannot be resolved. IL36RN upregulation alongside IL36A/G suggests complex feedback dynamics that single-timepoint data cannot fully capture.

### Program 2: Epidermal Differentiation and Cornified Envelope Dysregulation
- **Direction**: Upregulated
- **Supporting genes**: SPRR2A (7.31), SPRR2B (6.38), SPRR2D (5.92), SPRR2E (3.99), SPRR2F (7.22), SPRR2G (4.75), SPRR3 (7.18), LCE3A (8.30), LCE3D (5.31), KRT6A (4.30), PI3 (9.24), KLK13 (4.05), GJB2 (4.42), GJB6 (3.02)
- **Standardized pathway**: Reactome Formation of the cornified envelope (R-HSA-6809371); GO Epidermis Development (GO:0008544)
- **Explanation**: The coordinated upregulation of small proline-rich proteins (SPRR2 family), late cornified envelope proteins (LCE3A/D), keratin 6A, and the protease inhibitor PI3 (elafin) reflects the psoriatic "regenerative maturation" phenotype. This is not simple terminal differentiation but rather a dysregulated program where hyperproliferative keratinocytes prematurely express cornification markers. The STRING network evidence shows SPRR2B connected to LCE3A/LCE3D/SPRR2D/SPRR2E/SPRR2F, and SPRR1B connected to KRT6A/SPRR2A/SPRR2B/SPRR2D/SPRR2E, confirming these as a tightly co-regulated module.
- **Evidence strength**: Strong. Multiple independent gene families (SPRR, LCE, KRT) converge on the same biological program. The genetic deletion of LCE3B/LCE3C (flanking LCE3A/D) is a well-established psoriasis risk locus (GWAS).
- **Limitations**: The cornified envelope program is shared with other hyperproliferative skin conditions (wound healing, atopic dermatitis in some phases); it is not psoriasis-specific.

### Program 3: Antimicrobial Peptide and S100 Alarmin Response
- **Direction**: Upregulated
- **Supporting genes**: DEFB4A (11.18), DEFB4B (11.03), DEFB103A (5.76), DEFB103B (5.75), S100A7 (7.09), S100A7A (9.83), S100A8 (7.73), S100A12 (8.33), FABP5 (3.64), TCN1 (8.04)
- **Standardized pathway**: GO Antimicrobial Humoral Response (GO:0019730); KEGG Staphylococcus aureus infection
- **Explanation**: β-defensins (DEFB4A/B, DEFB103A/B) and S100 alarmins are massively upregulated. In psoriasis, these antimicrobial peptides are induced by IL-17 and IL-36 signaling in keratinocytes. S100A8/S100A9/S100A12 form hetero/homodimers that act as damage-associated molecular patterns (DAMPs) activating TLR4 and RAGE. The STRING network shows S100A7 connected to FABP5, S100A12, S100A7A, SERPINB3, SERPINB4, indicating a co-regulated module. TCN1 (transcobalamin 1) upregulation may relate to the neutrophil-rich infiltrate.
- **Evidence strength**: Strong. The scale of upregulation (log2FC 5.8–11.2) is remarkable and consistent across multiple defensin and S100 family members.
- **Limitations**: The antimicrobial program is partially shared with the cornified envelope program (many S100 genes are also epidermal differentiation markers). The functional significance of antimicrobial peptides in psoriasis pathogenesis versus merely reflecting the inflammatory state remains debated.

### Program 4: Protease/Antiprotease Imbalance and Tissue Remodeling
- **Direction**: Upregulated (with some downregulated genes in related processes)
- **Supporting genes**: SERPINB3 (6.74), SERPINB4 (9.12), SERPINB11 (4.47), SERPINB13 (3.09), KLK13 (4.05), PRSS27 (4.24), TMPRSS11D (7.75), HPSE (2.92), PLA2G4D (4.61), PLA2G4E (2.47), KYNU (4.42), HABP2 (4.19)
- **Standardized pathway**: KEGG Cytokine-cytokine receptor interaction (for related signaling); GO Response To Lipopolysaccharide (GO:0032496)
- **Explanation**: The coordinated upregulation of serine protease inhibitors (SERPINB3/B4/B11/B13) alongside kallikrein-related peptidase KLK13 and the transmembrane protease TMPRSS11D indicates a disrupted protease-antiprotease balance in lesional skin. SERPINB3/B4 are classical psoriatic markers. PLA2G4D/E (phospholipases A2) generate pro-inflammatory lipid mediators. HPSE (heparanase) and HABP2 (hyaluronan-binding protein) suggest extracellular matrix remodeling. KYNU (kynureninase) indicates tryptophan metabolism activation, which produces immunomodulatory metabolites.
- **Evidence strength**: Moderate-strong. Multiple independent protease and antiprotease genes are concordantly upregulated.
- **Limitations**: The functional consequences of this protease imbalance (net proteolysis versus net inhibition) cannot be determined from expression data alone.

### Program 5: Immune Cell Recruitment and Checkpoint Modulation
- **Direction**: Upregulated
- **Supporting genes**: CXCL13 (5.89), CXCR2 (2.70), CD274/PD-L1 (3.44), ADGRF1 (6.64), GPR15LG (5.52), HRH2 (3.27), PRKCQ (2.88), CDK5R1 (2.35), ADAP2 (2.09), TRIM15 (4.54), TRIM10 (4.04)
- **Standardized pathway**: KEGG Cytokine-cytokine receptor interaction; GO Response To Lipopolysaccharide (GO:0032496)
- **Explanation**: CXCL13 (B-cell chemoattractant) and CXCR2 (neutrophil receptor) indicate both lymphoid and myeloid recruitment. CD274 (PD-L1) upregulation suggests an immunoregulatory checkpoint response within the inflammatory lesion. PRKCQ (PKC-θ) is a T-cell activation gene. ADGRF1 (G-protein coupled receptor) and GPR15LG may modulate immune cell trafficking. TRIM15/TRIM10 are innate immune regulators. HRH2 (histamine receptor H2) could modulate keratinocyte and immune cell responses.
- **Evidence strength**: Moderate. The individual genes are statistically robust, and the pattern is consistent with the known mixed cellular infiltrate of psoriatic plaques. However, the specific functional roles of several of these genes (ADGRF1, GPR15LG, TRIM15/10) in psoriasis are less established.
- **Limitations**: Bulk tissue cannot resolve which cell types express these genes; single-cell RNA-seq would be needed.

---

## 3. Key Genes and Interaction Modules

### 1. IL36A / IL36G / IL36RN (IL-36 axis module)
- **Direction**: All upregulated (IL36A log2FC 11.37, IL36G 5.68, IL36RN 3.01)
- **Role**: Central mediators of the inflammatory program in keratinocytes; IL36RN is the natural antagonist.
- **Gene-gene relationship**: Direct physical interaction — STRING records show IL36RN interacts with IL1RL2 (confidence 0.999), IL36B (0.989), IL36G (0.864), and IL1RAP (0.854). These are ligand-receptor and receptor-co-receptor interactions. IL36A/G signal through IL1RL2/IL1RAP; IL36RN competes for IL1RL2 binding.
- **Evidence**: Direct (this dataset), pathway (Reactome Interleukin-36 pathway), protein interaction (STRING), disease-association (IL36RN loss-of-function mutations cause generalized pustular psoriasis — a related but distinct phenotype).
- **Verdict**: Established evidence for involvement in lesional psoriasis; supported hypothesis for its central mechanistic role.

### 2. DEFB4A / DEFB4B / DEFB103A / DEFB103B (β-defensin module)
- **Direction**: All strongly upregulated (log2FC 5.75–11.18)
- **Role**: Antimicrobial peptides; also chemoattractants for immune cells; copy number variation at the DEFB locus is a psoriasis risk factor.
- **Gene-gene relationship**: Pathway co-membership and likely co-regulation (STRING shows CCR6 as a common interaction partner, suggesting these defensins may act through CCR6-dependent chemotaxis). These are not direct physical interactors with each other but share functional roles.
- **Evidence**: Direct (this dataset), disease-association (GWAS: DEFB copy number variation associated with psoriasis).
- **Verdict**: Established evidence for differential expression; supported hypothesis for functional contribution.

### 3. S100A7 / S100A7A / S100A8 / S100A12 (S100 alarmin module)
- **Direction**: All strongly upregulated (log2FC 7.09–9.83)
- **Role**: DAMPs activating TLR4/RAGE; S100A7 (psoriasin) is a classic psoriatic marker with antimicrobial and chemotactic functions.
- **Gene-gene relationship**: Co-expression and pathway co-membership; STRING shows S100A7 connected to S100A12, S100A7A, FABP5, SERPINB3, SERPINB4. S100A8/S100A9 form heterodimers (calprotectin) — this would be a direct physical interaction, but S100A9 was not in the selected gene list.
- **Evidence**: Direct (this dataset), expression/tissue-specific (classic psoriatic keratinocyte markers).
- **Verdict**: Established evidence for differential expression.

### 4. SPRR2 family / LCE3A / LCE3D (Cornified envelope module)
- **Direction**: All upregulated (log2FC 3.99–8.30)
- **Role**: Terminal differentiation markers; LCE3 genes are adjacent to the psoriasis-associated LCE3B/LCE3C deletion.
- **Gene-gene relationship**: Co-expression and pathway co-membership (Reactome Formation of the cornified envelope). STRING network shows SPRR2B connected to LCE3A, LCE3D, SPRR2D, SPRR2E, SPRR2F. These are not direct physical interactors in most cases, though SPRR and LCE proteins do crosslink during cornification.
- **Evidence**: Direct (this dataset), genetic (LCE3B/C deletion is a psoriasis risk locus), pathway (Reactome).
- **Verdict**: Established evidence for differential expression; the LCE3 deletion association provides independent genetic support.

### 5. SERPINB3 / SERPINB4 (Squamous cell carcinoma antigens)
- **Direction**: Upregulated (log2FC 6.74 and 9.12)
- **Role**: Serine protease inhibitors; classic markers of psoriatic epidermis; also overexpressed in squamous cell carcinoma.
- **Gene-gene relationship**: Co-expression with S100A7 (STRING); pathway co-membership in cornified envelope formation. SERPINB3/B4 are adjacent genes with high sequence similarity — likely co-regulated.
- **Evidence**: Direct (this dataset), expression/tissue-specific (well-established psoriatic markers).
- **Verdict**: Established evidence for differential expression; functional role in psoriasis remains incompletely defined.

### 6. IL19 / IL20 / IL26 (IL-20 family module)
- **Direction**: All upregulated (log2FC 4.36–7.58)
- **Role**: IL-20 family cytokines promote keratinocyte hyperproliferation and are implicated in psoriasis pathogenesis.
- **Gene-gene relationship**: Pathway co-membership (Reactome Interleukin-20 family signaling). IL19 and IL20 share receptor subunits (IL20RA/IL20RB). These are not direct physical interactors with each other but share signaling pathways.
- **Evidence**: Direct (this dataset), pathway (Reactome), disease-association (IL-20 family implicated in psoriasis).
- **Verdict**: Established evidence for differential expression; supported hypothesis for pathogenic role.

### 7. CXCL13 / CXCR2 (Chemokine module)
- **Direction**: Both upregulated (CXCL13 log2FC 5.89, CXCR2 2.70)
- **Role**: CXCL13 recruits B cells and follicular helper T cells; CXCR2 is a neutrophil/myeloid chemokine receptor.
- **Gene-gene relationship**: These are ligand-receptor pairs but for different cell populations — CXCL13 binds CXCR5 (not CXCR2). They represent parallel recruitment programs, not a direct interaction pair.
- **Evidence**: Direct (this dataset); CXCL13 upregulation in psoriasis is documented.
- **Verdict**: Supported hypothesis for immune cell recruitment.

### 8. CD274 (PD-L1)
- **Direction**: Upregulated (log2FC 3.44)
- **Role**: Immune checkpoint ligand; upregulation may represent a regulatory feedback mechanism in inflamed skin.
- **Gene-gene relationship**: Not directly interacting with other selected genes; likely induced by inflammatory cytokines (IFN-γ, IL-17).
- **Evidence**: Direct (this dataset); literature support for PD-L1 upregulation in psoriatic skin.
- **Verdict**: Supported hypothesis; functional significance (immunosuppressive feedback versus disease-promoting) requires functional validation.

### 9. WNT5A
- **Direction**: Upregulated (log2FC 2.53)
- **Role**: Non-canonical Wnt signaling; implicated in keratinocyte proliferation and inflammation.
- **Gene-gene relationship**: Pathway co-membership with other selected genes is not evident from the retrieved data; WNT5A may act in an autocrine/paracrine manner on keratinocytes and immune cells.
- **Evidence**: Direct (this dataset); literature evidence for WNT5A in psoriatic epidermis.
- **Verdict**: Supported hypothesis.

### 10. KYNU / AKR1B10 / AKR1B15 (Metabolic adaptation module)
- **Direction**: All upregulated (KYNU log2FC 4.42, AKR1B10 6.27, AKR1B15 5.23)
- **Role**: KYNU is a kynurenine pathway enzyme (tryptophan metabolism → immunomodulatory metabolites); AKR1B10/B15 are aldo-keto reductases involved in retinoid metabolism and detoxification.
- **Gene-gene relationship**: Co-expression within the metabolic adaptation program; no direct physical interaction evidence retrieved.
- **Evidence**: Direct (this dataset); AKR1B10 has been reported in psoriatic skin; kynurenine pathway activation is documented in inflammatory skin.
- **Verdict**: Supported hypothesis for metabolic reprogramming in lesional skin.

---

## 4. Validation Priorities

### Priority 1: IL-36 axis functional validation (Mechanistic hypothesis)
- **Why**: IL36A shows the highest log2FC in the dataset (11.37); the IL-36 axis is a plausible upstream driver of the entire inflammatory program.
- **Dataset evidence**: IL36A, IL36G, and IL36RN are all strongly upregulated with FDR < 4e-62.
- **External evidence**: IL36RN mutations cause generalized pustular psoriasis (genetic evidence, independent of expression data). IL-36 blockade is in clinical development for psoriasis and related conditions.
- **Next step**: In keratinocyte culture or mouse models, test whether IL-36 neutralization suppresses the downstream SPRR/S100/defensin program; examine IL36RN/IL36A ratio dynamics.
- **Status**: Supported hypothesis (the expression data are strong, but causal direction requires functional testing).

### Priority 2: Cell-type deconvolution / single-cell validation (Confounding or composition check)
- **Why**: Bulk tissue cannot distinguish keratinocyte, neutrophil, T-cell, or dendritic-cell contributions to the observed signals.
- **Dataset evidence**: The mixture of keratinocyte markers (SPRR, LCE, KRT6A), myeloid markers (S100A8/A9/A12), and lymphoid markers (CXCL13, PRKCQ) suggests mixed cellular origin.
- **External evidence**: Published single-cell RNA-seq of psoriatic skin shows cell-type-specific programs; our bulk data are consistent with these but cannot resolve them.
- **Next step**: Single-cell or spatial transcriptomics on matched lesional/non-lesional/normal skin; or computational deconvolution using reference signatures.
- **Status**: Required to interpret the current data; the bulk analysis itself cannot be validated for cell-type specificity.

### Priority 3: Confirm cornified envelope dysregulation at protein level (Biomarker)
- **Why**: The SPRR2/LCE3/KRT6A module is the most coherent differentiation program and includes genes near established psoriasis risk loci (LCE3B/C deletion).
- **Dataset evidence**: 12+ genes in the cornified envelope pathway are upregulated with FDR < 1e-61.
- **External evidence**: LCE3B/LCE3C deletion is a replicated GWAS finding; SPRR and LCE proteins are detectable in psoriatic scale.
- **Next step**: Immunohistochemistry or proteomics on lesional skin for SPRR2, LCE3, KRT6A; correlate with disease severity (PASI).
- **Status**: Supported hypothesis for the pathway; established evidence for differential expression.

### Priority 4: Test antimicrobial peptide contribution to disease (Therapeutic target / Mechanistic hypothesis)
- **Why**: The defensin and S100 modules show the highest fold-changes in the dataset; their functional contribution to psoriasis (versus being bystander antimicrobial responses) is debated.
- **Dataset evidence**: DEFB4A/B (log2FC > 11), S100A7A (9.83), S100A8 (7.73), S100A12 (8.33).
- **External evidence**: DEFB copy number variation is associated with psoriasis risk; S100A8/A9 are elevated in psoriatic serum and correlate with disease activity. However, direct causality is not established.
- **Next step**: In mouse models (e.g., IL-23-induced psoriasiform dermatitis), test whether S100 or defensin blockade reduces inflammation; or examine whether antimicrobial peptide levels predict treatment response.
- **Status**: Exploratory hypothesis for therapeutic targeting; established evidence for differential expression.

### Priority 5: Validate downregulated genes as potential protective/differentiation markers (Biomarker)
- **Why**: The downregulated set (BTC, CYP2W1, UGT3A2, SAPCD1, WAKMAR1, and several lncRNAs) is small but may represent genes suppressed during psoriatic inflammation.
- **Dataset evidence**: 10 genes with log2FC from -2.84 to -6.25, all FDR < 5e-61.
- **External evidence**: BTC (betacellulin) is an EGFR ligand; its suppression is unexpected given EGFR activation in psoriasis and needs verification. CYP2W1 and UGT3A2 are metabolic enzymes whose role in skin is poorly characterized.
- **Next step**: qPCR validation in an independent cohort; examine whether these genes are restored after successful treatment (e.g., anti-IL-17 therapy).
- **Status**: Exploratory hypothesis; the downregulation is statistically robust but biologically uncharacterized.

---

## 5. Evidence Grounding Summary

| Claim | Direct (this dataset) | Pathway/Ontology | Protein Interaction | Disease/Genetic | Expression/Tissue | Literature |
|---|---|---|---|---|---|---|
| IL-36 axis activated | ✓ (IL36A/G/RN, FDR < 4e-62) | ✓ (Reactome IL-36 pathway) | ✓ (STRING: IL36RN-IL1RL2-IL1RAP) | ✓ (IL36RN mutations in pustular psoriasis) | ✓ | ✓ |
| Cornified envelope dysregulated | ✓ (SPRR2A-G, LCE3A/D, KRT6A, PI3) | ✓ (Reactome R-HSA-6809371) | ✓ (STRING SPRR/LCE network) | ✓ (LCE3B/C deletion GWAS) | ✓ | ✓ |
| Antimicrobial response activated | ✓ (DEFB4A/B, DEFB103A/B, S100A7/A8/A12) | ✓ (GO:0019730) | Partial (STRING S100A7 module) | ✓ (DEFB CNV) | ✓ | ✓ |
| Immune cell recruitment | ✓ (CXCL13, CXCR2, CD274) | ✓ (KEGG cytokine-cytokine receptor) | Limited | Partial | ✓ | ✓ |
| Protease/antiprotease imbalance | ✓ (SERPINB3/B4/B11/B13, KLK13, TMPRSS11D) | ✓ | ✓ (STRING: CTSG-SERPINB3/B4/B13) | Partial | ✓ | ✓ |

**Independence assessment**: The pathway/ontology and network records may derive from the same underlying literature and annotation sources. The GWAS evidence (LCE3B/C deletion, DEFB CNV) is genuinely independent of expression data. The IL36RN mutation evidence is independent of the IL36A/G expression changes in this dataset. However, the Reactome and STRING annotations may share source publications and are not fully independent of each other.

---

## 6. Limitations and Alternative Explanations

### Limitation 1: Tissue composition differences
Psoriatic lesional skin contains a markedly different cell composition than normal skin, with infiltrating neutrophils, T cells, dendritic cells, and macrophages. Many of the observed changes (S100A8/A9/A12, CXCR2, CXCL13, CD274) may reflect the cellular infiltrate rather than intrinsic keratinocyte changes. **Investigation**: Single-cell RNA-seq or spatial transcriptomics; computational deconvolution; immunohistochemistry for key markers.

### Limitation 2: Disease severity and treatment exposure not controlled
The dataset does not specify disease severity (PASI), disease duration, or prior/current treatment. Patients on systemic therapy (biologics, methotrexate) would show attenuated inflammatory programs. **Investigation**: Collect treatment history and severity scores; stratify analyses; validate in treatment-naïve patients.

### Limitation 3: Association versus causation
All findings are correlational. The upregulation of IL36A/G, defensins, and S100 proteins could be either drivers or consequences of the inflammatory state. The IL36RN genetic evidence suggests the IL-36 axis is upstream, but this is not proof for the specific genes in this dataset. **Investigation**: Functional perturbation studies (IL-36 blockade, S100 knockout) in relevant models.

### Limitation 4: Batch and platform effects
No information is provided about the sequencing platform, sample processing, or batch structure. The extreme effect sizes and uniformly tiny P values could reflect a strong biological signal or technical artifacts (e.g., batch separation between cases and controls). **Investigation**: Verify with qPCR in an independent cohort; examine principal components; confirm that the top genes are not known batch-sensitive artifacts.

### Limitation 5: Broad and overlapping pathway enrichment
The cornified envelope, antimicrobial, and S100 programs overlap substantially and may not represent truly independent biological processes. Many of these genes are co-regulated by the same transcription factors (e.g., KLF4, AP-1) and may reflect a single "psoriatic keratinocyte state" rather than multiple distinct programs. **Investigation**: Transcription factor motif analysis; chromatin accessibility (ATAC-seq); compare with atopic dermatitis and wound healing datasets to identify psoriasis-specific versus shared programs.

---

## Final Summary

This dataset provides an extremely robust transcriptomic signature of psoriatic lesional skin, dominated by IL-36/IL-20 family cytokine activation, dysregulated cornified envelope formation, massive antimicrobial peptide and S100 alarmin upregulation, and evidence of immune cell recruitment — all with FDR < 1e-60 for essentially every gene. The IL-36 axis (IL36A, IL36G, IL36RN), cornified envelope module (SPRR2, LCE3, KRT6A), and antimicrobial peptide module (DEFB4A/B, S100A7/A8/A12) represent the most defensible core programs supported by multiple independent genes, pathway annotations, and (for IL36RN and LCE3) independent genetic evidence. However, external statistical validation in an independent cohort was not performed, and the bulk-tissue design cannot resolve cell-type contributions or establish causality; these limitations should be explicitly addressed in any follow-up study before translational conclusions are drawn.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=5, external claims checked=0, external mismatches=0, status=passed.

Answer model API: deepseek / deepseek-v4-flash.

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 91/100 selected items (records returned); cbioportal 91/100 selected items (records returned); chembl 11/100 selected items (partially returned; some queries failed); civic 4/100 selected items (records returned); clinicaltrials 40/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 44/100 selected items (partially returned; some queries failed); europepmc 848 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 83/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 76/100 selected items (records returned); humanbase 100/100 selected items (records returned); intact 79/100 selected items (records returned); mygene 100/100 selected items (records returned); omnipath 36/100 selected items (records returned); opentargets 90/100 selected items (records returned); pubmed 669 articles / initial full-cohort RAG 100 queries + 3 current-round queries; some queries failed; quickgo 80/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 80/100 selected items (records returned)
Local databases: gutmgene 2/100 selected items (records returned); hmdb 25/100 selected items (records returned); string 78/100 selected items (records returned); trrust 17/100 selected items (records returned)
